Загрузка...
Small interfering RNA for cancer treatment: overcoming hurdles in delivery
In many ways, cancer cells are different from healthy cells. A lot of tactical nano-based drug delivery systems are based on the difference between cancer and healthy cells. Currently, nanotechnology-based delivery systems are the most promising tool to deliver DNA-based products to cancer cells. Th...
Сохранить в:
| Опубликовано в: : | Acta Pharm Sin B |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7714980/ https://ncbi.nlm.nih.gov/pubmed/33304780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.10.005 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|